Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

With list prices of $8.94 per day for the monotherapy and metformin combinations, the companies are hoping to gain ground on Farxiga and Jardiance by undercutting them – Farxiga costs $11.57 per ...

Under the IRA, companies that refuse to reduce prices risk an excise tax starting ... became clear that its big-selling diabetes treatment Jardiance (empagliflozin) – sold with Eli Lilly ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...

You could be paying more for a new Rolex watch at an authorized dealer in 2025 after used Rolex prices continued falling last year. But rising retail prices could be good news for collectors and ...

HOUSTON, Jan 7 (Reuters) - Oil prices settled higher on Tuesday, driven by concerns over limited supply from Russia and Iran because of Western sanctions and expected higher Chinese demand.